| Title |
Fatigue in lung cancer patients: symptom burden and management of challenges
|
|---|---|
| Published in |
Lung Cancer: Targets and Therapy, May 2016
|
| DOI | 10.2147/lctt.s85334 |
| Pubmed ID | |
| Authors |
Simona Carnio, Rosario Francesco Di Stefano, Silvia Novello |
| Abstract |
Lung cancer (LC) remains the most common cause of cancer death in several countries across the world. Fatigue is the most frequently reported symptom in LC patients throughout the entire course of disease, and all international guidelines recommend early screening for cancer-related fatigue (CRF) and symptoms that can affect patients' quality of life. In patients with LC, fatigue belongs to the symptom cluster of pain, depression, and insomnia, which are commonly observed simultaneously, but are typically treated as separate although they may have common biological mechanisms. The treatment of CRF remains one of the difficult areas in the oncology field: scarce evidence supports pharmacological therapies, while some interesting data arising indicates alternative remedies and physical exercise seem to be one of the most effective approaches for CRF at any stage of LC. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 129 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 16% |
| Student > Bachelor | 16 | 12% |
| Student > Doctoral Student | 13 | 10% |
| Researcher | 12 | 9% |
| Student > Postgraduate | 5 | 4% |
| Other | 16 | 12% |
| Unknown | 47 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 20% |
| Nursing and Health Professions | 22 | 17% |
| Psychology | 12 | 9% |
| Computer Science | 3 | 2% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 14 | 11% |
| Unknown | 50 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2023.
All research outputs
#1,306,934
of 25,371,288 outputs
Outputs from Lung Cancer: Targets and Therapy
#2
of 128 outputs
Outputs of similar age
#21,923
of 311,861 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 6 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,861 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them